Anthony Quinn

Companies

• Generation Bio Co.Board member Jun 11, 2020 to now¹
• Aeglea BioTherapeuticsPresident Jul 20, 2018 to Mar 18, 2022²
• Aeglea BioTherapeuticsChief executive officer Sep 1, 2017 to Mar 18, 2022³
• Aeglea BioTherapeuticsBoard member Apr 6, 2016 to Mar 18, 2022⁴
• Kaleido Biosciences, Inc.Board member Feb 27, 2019 to Jul 1, 2021⁵
• Aeglea BioTherapeuticsinterim Chief Medical Officer Apr 25, 2017 to Apr 25, 2017⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAeglea BioTherapeutics SYRE816,835 shares⁷$69.9M at $85.57Mar 18, 2022
• GBGeneration Bio Co.0 shares⁸Feb 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 9, 2026U 7,283 shares of Generation Bio Co.⁸
• Feb 9, 2026U 29,928 shares of Generation Bio Co.⁸
• Jan 13, 2025Bought 85,000 shares at $0.97 of Generation Bio Co.⁹
• Jan 10, 2025Bought 125,791 shares at $0.96 of Generation Bio Co.⁹
• Dec 1, 2023Bought 88,495 shares at $1.41 of Generation Bio Co.¹⁰
• Mar 16, 2022Bought 80,079 shares at $2.34 of Aeglea BioTherapeutics⁷
• Mar 15, 2022Bought 42,417 shares at $1.86 of Aeglea BioTherapeutics¹¹
• Mar 14, 2022Bought 67,472 shares at $1.93 of Aeglea BioTherapeutics¹¹
• Mar 11, 2022Bought 34,777 shares at $2.06 of Aeglea BioTherapeutics¹¹
• Dec 10, 2021Bought 10,526 shares at $3.75 of Aeglea BioTherapeutics¹²
• Dec 9, 2021Bought 43,108 shares at $3.70 of Aeglea BioTherapeutics¹²
• Oct 28, 2021Gift 72,837 shares of Generation Bio Co.¹³
• Oct 28, 2021Gift 72,837 shares of Generation Bio Co.¹³
• Oct 20, 2021Gift 10,000 shares of Aeglea BioTherapeutics¹⁴
• Oct 20, 2021Gift 10,000 shares of Aeglea BioTherapeutics¹⁴
• Oct 18, 2021Gift 23,809 shares of Aeglea BioTherapeutics¹⁴
• Oct 18, 2021Gift 23,809 shares of Aeglea BioTherapeutics¹⁴
• Oct 14, 2021Gift 175,036 shares of Aeglea BioTherapeutics¹⁴
• Oct 14, 2021Gift 175,036 shares of Aeglea BioTherapeutics¹⁴
• Dec 28, 2018Gift 57,450 shares of Aeglea BioTherapeutics¹⁴
• Dec 28, 2018Gift 57,450 shares of Aeglea BioTherapeutics¹⁴